Robots for Medical Device Manufacturing

LIVERMORE, Calif.--(BUSINESS WIRE)--April 25, 2006--Adept Technology, Inc. (NASDAQ:ADEP) announced a major medical device automation program with Insulet Corporation for the OmniPod(TM) Insulet Management System, a disruptive technology for insulin delivery in diabetes management.

Insulet's groundbreaking OmniPod is being assembled in the USA. "Insulet is ramping up large-scale manufacturing and requires rapid deployment of Adept's robotics in our clean room environment," says Kevin Schmid, VP of Manufacturing. "Adept has a proven track record in clean room robotics and the ability to scale to meet our demand."

Says Janine Roth, Vice President Marketing, Adept Technology. "Insulet is an excellent example of a company gaining competitive edge via its progressive manufacturing approach."

Sal Spada, Research Director for ARC Advisory Group, commented, "As medical devices become smaller, more complex, and individually customized it is economically unfeasible to consider an assembly operation without robotics. Based on these drivers, ARC Advisory Group's most recent assessment of the robotics market projected that the medical device sector would outpace the overall market growth for robotic solutions. As such, over the next five years the robotic shipments into the medical device sector will surpass an 11 percent annual growth."

Adept: News Release